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Open aca b s t r a c t
Objectives: To explore the eventual connection between iron deﬁciency anemia (IDA) in infancy and
altered leg movements during sleep in a 10-year follow-up study in children who did or did not have
IDA in infancy.
Subjects and methods: Polysomnographic studies were performed in 32 10-year-old children (13 females
and 19 males) who had IDA in infancy and 26 peers (10 females and 16 males) who were nonanemic con-
trols. The time structure of their polysomnographically recorded leg movements (LM) was analyzed by
means of an approach particularly able to consider their quantity, periodicity, and distribution during
the night.
Results: All LM indexes and those related to periodic LM during sleep (PLMS) were slightly higher in the
former IDA group than in the control group, but not always signiﬁcant. The Periodicity index during
NREM sleep was higher and was reﬂected by a small but signiﬁcant increase in PLMS separated by
10–50 s intervals. PLMS index tended to be higher in former IDA children than in controls throughout
the whole night.
Conclusion: The association between IDA in infancy, despite iron therapy, and PLMS in childhood could
lead to new research in this area. Indeed, transient infantile IDA, a common nutritional problem among
human infants, may turn out to be important for understanding the mechanisms of PLMS or restless legs
syndrome, which are common in adulthood.
 2012 Published by Elsevier B.V. Open access under CC BY-NC-ND license. 1. Introduction
Iron deﬁciency (ID) is prevalent in human infants, especially in
the late infancy/toddler period (between the ages of six and
24 months) [1–5]. There is mounting evidence that ID affects mo-
tor activity, not only in animal studies [6–12], but also in humans.
In the adult human, maximal physical performance, submaximal
endurance, and work productivity have been shown to be reduced
in iron deﬁciency anemia (IDA) and, in some cases, in ID without
anemia [13–17]. The few published studies of ID andmotor activity
in school-aged children report decreased activity while awake [18].
In the human infant Lozoff et al. [19] found decreased activity in a
study of play behavior and mother-infant interaction. In another
study of 12- to 18-month-old undernourished infants with IDA,ep and Functional Neurobiol-
A), University of Chile, Av. El
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cess under CC BY-NC-ND license. Harahap et al. [20] found reduced Bayley motor scores and motor
activity scores, in comparison to controls, before iron therapy.
Following iron treatment, the activity of IDA infants increased to
a larger extent than controls. Using actigraphs, in a laboratory set-
ting, Angulo-Kinzler et al. [21] found decreased frequency of motor
activity at 12 and 18 months in infants who were anemic (IDA) at
six months and received iron treatment beginning at that age.
These results were limited to a short-term period of observation
(activity during the waking time immediately preceding and
following an afternoon nap in the laboratory). Using 24-h acti-
graphic recordings in the home, Angulo-Kinzler et al. [22] reported
that six-month-old infants with IDA showed an overall increase in
motor activity compared to controls, with actigraphs worn on the
ankle; differences were no longer observed at 12 and 18 months of
age after effective iron supplementation treatment. We hypothe-
sized that increased leg activity during the period of IDA might
indicate a shared underlying mechanism with restless legs
syndrome (RLS). RLS is a sensorimotor dysfunction where ID is
suspected to play an important pathogenic role. ID might trigger
RLS symptoms and might worsen a pre-existing RLS form, and iron
P. Peirano et al. / Sleep Medicine 13 (2012) 1006–1012 1007supplementation can ameliorate them [23], but its relation to IDA
in infancy has not been investigated.
We had a chance to explore a connection between IDA in in-
fancy and altered leg movements in a 10-year follow-up performed
at INTA, University of Chile, within an ongoing collaborative re-
search project with University of Michigan. We studied motor
activity during sleep as recorded from the tibialis anterior muscles
of 10-year-old children who did or did not have IDA in infancy. We
focused on the so-called periodic leg movements during sleep
(PLMS), a typical sleep-related motor phenomenon usually found
in more than 80% of affected individuals with RLS [24]. We ana-
lyzed PLMS by means of a new approach that has been shown to
be particularly able to describe the periodicity of this motor pat-
tern [25].2. Subjects and methods
2.1. Subjects
The children in this study are participants in ongoing research
in Chile on the behavioral, developmental, neurosensory, cognitive,
and sleep–wake patterns effects of IDA in infancy. Detailed
descriptions of the population and ﬁndings during infancy have
been published elsewhere [26,27]. In brief, study participants were
healthy full-term infants (birth weightsP3.0 kg, no perinatal com-
plications, and no acute or chronic illnesses). Infants were assessed
for IDA at 6, 12, and 18 months. Anemia was deﬁned as venous
hemoglobin 6100 g/L at six months and <110 g/L at 12 and
18 months (for details see Lozoff et al. [26]). ID was deﬁned as
two of three iron measures in the iron-deﬁcient range (mean cell
volume <70 ﬂ, erythrocyte protoporphyrin >100 lg/dL red blood
cells [1.77 lmol/L], serum ferritin <12 lg/L). For each IDA infant,
an infant of the same age who was clearly nonanemic (venous
hemoglobin P115 g/L) was randomly selected. They constituted
the ‘‘control’’ group. Six-month-old infants were treated for one
year with 15 mg/day of elemental iron as oral ferrous sulphate; in-
fants identiﬁed at 12 or 18 months were treated with oral iron
(30 mg/day) for a minimum of six months. Given that IDA in in-
fancy was very common in the population at the time, infants from
the control group underwent the same iron treatment in order to
assure they did not become anemic with advancing age.
As part of the 10-year-old follow-up, we compared tibialis ante-
rior activity patterns during sleep between 32 children (13 females
and 19 males) who had IDA in infancy (former IDA) and 26 children
(10 females and 16 males) who were nonanemic controls. All were
healthy and not taking any medications at the time of polysomno-
graphic recording. The sex distribution was not different betweenTable 1
Background characteristics of the two groups of subjects studied.
Former IDA (n =
Males, n (%) 19 (59.4%)
Age at 10 year testing (years) 10.08 (0.11)
BMI (kg/m2) 19.00 (3.52)
Birth weight (g) 3467.8 (362.2)
Gestational age (weeks) 39.34 (0.94)
Cow milk/formula consumptiona (ml/day) 301.1 (138.0)
Iron sufﬁcient at 10 years, n (%) 29 (93.6%)
Parental RLSb (%) 14.8
Apnea/hypopnea index 0.58 (0.62)
ADHD scorec 11.2 (4.1)
Means (S.D.) are shown, unless otherwise noted; p values are from t-tests for continuous v
vary slightly due to occasional missing data in some measures. BMI = body mass-index.
NS = not signiﬁcant differences.
a This is the average daily intake throughout the supplementation study, that is, from
b In one or both biologic parents; ADHD = Attention-deﬁcit hyperactivity disorder.
c Subtype aggressive, impulsive, hyperactive.the two groups (Chi-square = 0.001, d.f. = 1, p = 0.963). Table 1
shows the background characteristics of the groups. There were
no statistically signiﬁcant differences in child or family factors,
including attention deﬁcit and hyperactivity disorder (ADHD)
subtype (aggressive, impulsive, hyperactive) score and apnea/
hypopnea index (AHI) in children, as well as the prevalence of a
positive family history of RLS in one or both biologic parents.
The research protocol was approved by the Institutional Review
Boards of the University of Michigan Medical Center, Ann Arbor, of
INTA, University of Chile, Santiago, and of the Ofﬁce of Protection
from Research Risks, NIH. Parental signed informed consent and
child assent was obtained.
2.2. Nocturnal polysomnography
Subjects were allowed to sleep until they spontaneously woke
up in the morning. Lights-out time was based on individual habit-
ual bed time and ranged between 9:30 and 11:30 p.m. The follow-
ing signals were recorded during polysomnography: EEG (six
channels, F4, C4, O2, F3, C3, O1, referred to the contralateral ear-
lobe); electrooculogram (electrodes placed 1 cm above the right
outer cantus and 1 cm below the left outer cantus and referred
to A1), electromyogram (EMG) of the submentalis muscle, ECG
(one derivation), body position, and temperature. EMG of the right
and left tibialis anterior muscles (bipolar derivations with two
electrodes placed 3 cm apart on the belly of the anterior tibialis
muscle of each leg, impedance was kept less than 10 KX), accord-
ing to the WASM-IRLSSG scoring criteria [28]. Sleep signals were
sampled at 200 Hz and stored on hard disk in European data for-
mat (EDF, see Kemp et al. [29] for details) for further analysis.
EMG signals, in particular, were digitally band-pass ﬁltered at
10–100 Hz, with a notch ﬁlter at 50 Hz. The sleep respiratory pat-
tern of each patient was also monitored using nasal pressure can-
nula and oral airﬂow thermistor, abdominal respiratory effort
strain gauge, snoring by microphone, and by monitoring oxygen
saturation (pulse-oxymetry). Subjects with an AHIP5 were not in-
cluded. All sleep measures were acquired and processed without
knowledge of whether a given child was former IDA or control.
2.3. Sleep scoring and detection of leg movements
Prior to any recording we veriﬁed that the EMG amplitude re-
corded from the two tibialis anterior muscles was below 2 lV at
rest and exceeded 7–10 lV for small voluntary ﬂexions of the foot.
EMG amplitude at maximal deﬂection was also measured for the
application of the WASM-IRLSSG scoring criteria [28]. In all sub-
jects, sleep was subdivided into 30-s epochs, and sleep stages were32) Controls (n = 26) p Value
16 (61.5%) NS
10.05 (0.06) NS
19.70 (3.43) NS
3558.5 (411.8) NS
39.38 (0.94) NS
235.3 (167.2) NS
23 (92.0%) NS
10.8 NS
0.54 (0.43) NS
12.7 (3.5) NS
ariables, and from chi-squared test for categorical variables; the number of subjects
six to 12 months; RLS = Restless legs syndrome.
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Kales [30] using the sleep analysis software Hypnolab 1.2 (SWS
Soft, Italy). Leg movements (LMs) during sleep were ﬁrst detected
by the same software that allows their computer-assisted detec-
tion. With this software, the detection is performed using a hu-
man-supervised automatic approach controlled by the scorer that
uses the WASM-IRLSSG scoring criteria [28]. The performance of
this system has been evaluated and validated [31]. In this study
one scorer also visually edited the detections proposed by the
automatic analysis before computing a ﬁnal result. The total LM in-
dex was calculated as the total number of LMs per hour of sleep.
The PLMS index was calculated as the number of LMs in a series
of four or more, separated by more than 5 and less than 90 s, per
hour of sleep [28].2.4. Further analysis of leg movement architecture
In this analysis we used the newly described approach to study
LM periodicity [25]. These parameters are in line with those pro-
posed by the WASM-IRLSSG [28] and include, in particular, the
Periodicity Index computed as the number of sequences of three
inter-LM intervals 10 < i 6 90 s/total number of inter-LM intervals
[25]. This index can vary between zero (absence of periodicity) to
one (all intervals with length 10 < i 6 90 s). Periodicity index is
independent of the absolute number of LMs recorded.2.5. Statistical analysis
The comparison between the different sleep scoring and LM
parameters obtained from children with or without IDA in infancy
was carried out by means of the Student’s t-test for independent
data sets after controlling for the normality of distribution of data.
The comparison between groups in the number of PLMS during
each hour of the night was performed using a zero-inﬂated Poisson
regression model [32]; this approach was chosen due to the excess
number of zero PLMS for individual hours of the night. Statistical
analyses were conducted using SAS and STATISTICA data analysis
software system version 6. (StatSoft Inc., 2001. www.statsoft.com).3. Results
3.1. Sleep architecture
Table 2 reports the sleep architecture parameters in the two
groups of children. Former IDA children showed a longer sleep
latency and lower number of stage shifts and awakenings thanTable 2
Comparison between sleep architecture parameters obtained in the two groups of childre
Former IDA (n = 32)
Mean S.D.
Time in bed, min 524.6 67.56
Sleep period time, min 466.6 60.57
Total sleep time, min 435.3 72.25
Sleep latency, min 37.2 35.13
REM sleep latency, min 161.7 67.67
Stage shift/hour 4.9 1.79
Awakenings/hour 1.0 1.25
Sleep efﬁciency, % 83.3 11.07
Wakefulness after sleep onset, % 6.8 9.15
Sleep stage 1, % 7.7 3.88
Sleep stage 2, % 47.8 8.23
Slow-wave sleep, % 21.6 5.76
REM sleep, % 16.1 5.24
NS = not signiﬁcant.controls. However, these differences did not pass the conservative
Bonferroni correction.
3.2. Leg motor activity
Table 3 reports the parameters derived from the analysis of the
tibialis anterior EMG activity. All LM indexes and those related to
PLMS were slightly higher in former IDA subjects than in controls.
However, only the differences in total and NREM sleep PLMS index
reached statistical signiﬁcance. Former IDA subjects showed signif-
icantly longer LM than controls in both REM and NREM sleep;
however, none of these differences remained signiﬁcant after the
Bonferroni correction. The total sleep Periodicity index and that
calculated for NREM were signiﬁcantly higher in former IDA chil-
dren than in normal controls; also, these differences did not pass
the conservative Bonferroni correction for multiple comparisons.
3.3. Analysis of inter-LM intervals
Fig. 1 shows the distribution of inter-LM intervals in former IDA
children and controls. Former IDA children showed higher values
than normal controls for several interval classes depicted in this
ﬁgure, mostly for those in the range between 10 and 50 s. Consis-
tent with the results obtained for the Periodicity index (Table 3),
statistically signiﬁcant differences were found for some of these
interval classes, as indicated by asterisks.
3.4. Night distribution of LMs
Fig. 2 compares the distribution of the number of PLMS and iso-
lated LM and total LM per hour of sleep (ﬁrst eight hours shown)
between former IDA and control children. PLMS tended to be high-
er in former IDA children than in controls throughout the whole
night. The differences were statistically signiﬁcant for the ﬁrst,
third, sixth, seventh, and eighth hour of recording and marginally
signiﬁcant for the fourth hour (p = 0.071). In general, the differ-
ences between the two groups seemed to be more evident during
the last three hours of the night. Both groups showed a trend for
the number of PLMS to decrease throughout the night. There were
no group differences for the distribution of isolated LMs, which
showed a similar number in all hours of the night.
4. Discussion
The main ﬁnding of this study is that 10-year-old children who
experienced IDA in infancy showed a mild but signiﬁcant increase
of tibialis anterior EMG activity during sleep when compared ton.
Controls (n = 26) Student’s t-test
Mean S.D. t p<
533.8 64.14 0.521 NS
492.4 62.03 1.593 NS
444.4 67.55 0.488 NS
19.3 18.19 2.320 0.024
136.2 61.35 1.477 NS
6.5 3.02 2.491 0.016
2.3 2.78 2.422 0.019
83.5 9.75 0.056 NS
9.6 9.19 1.171 NS
7.7 3.29 0.028 NS
43.6 9.28 1.816 NS
22.7 6.64 0.687 NS
16.3 5.48 0.165 NS
Table 3
Comparison between the LM activity parameters obtained in the two groups of children.
Former IDA (n = 32) Controls (n = 26) Student’s t-test
Mean S.D. Mean S.D. t p<
NREM sleep
Total LM, index 15.4 8.48 11.4 6.08 1.982 NS
PLMS, index 8.8 7.60 5.0 4.50 2.214 0.03
Isolated LM, index 6.6 1.91 6.4 2.55 0.297 NS
REM sleep
Total LM, index 13.9 9.00 10.7 8.56 1.366 NS
PLMS, index 4.4 7.16 3.3 4.92 0.682 NS
Isolated LM, index 9.5 5.14 7.4 4.95 1.531 NS
Total sleep
Total LM, index 15.1 7.96 11.4 6.00 1.941 NS
PLMS, index 8.0 6.84 4.7 4.22 2.105 0.04
Isolated LM, index 7.1 2.11 6.6 2.66 0.683 NS
PLMS sequence, number 8.5 7.16 5.7 4.61 1.708 NS
PLMS sequence duration, s 17.2 23.54 12.4 18.77 0.836 NS
PLMS duration (REM), s 1.6 1.36 1.3 1.29 0.817 NS
PLMS duration (NREM), s 2.7 1.22 2.0 1.00 2.113 0.039
Isolated LM duration (REM), s 2.5 1.24 1.8 1.27 2.041 0.046
Isolated LM duration (NREM), s 2.8 0.99 2.1 1.00 2.410 0.019
Periodicity Index, total sleep 0.251 0.186 0.132 0.136 2.676 0.0097
Periodicity Index, NREM 0.242 0.187 0.132 0.143 2.433 0.018
Periodicity Index, REM 0.143 0.238 0.042 0.085 1.992 NS
NS = not signiﬁcant.
Fig. 1. Distribution histograms of inter-LM intervals during sleep of the two subject
groups. All values are shown as mean and SEM (whiskers). Asterisks indicate the
points for which a signiﬁcant difference was found between the graphs at statistical
analysis (Student’s t-test; p < 0.05).
Fig. 2. Comparison between the distribution of number of PLMS (top panel) and
isolated LMs (bottom panel) per hour of sleep (ﬁrst 8 h shown) between subject
groups. All values are shown as mean and SEM (whiskers). Asterisks indicate the
points for which a signiﬁcant difference was found between the graphs in each
panel at statistical analysis.
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slightly but signiﬁcantly higher periodicity due to a selective in-
crease of muscle activations separated by an interval ranging
approximately 10–50 s. Taken all together, these ﬁndings point
to the possibility that long-term consequences of IDA in infancy,
despite iron therapy, can be detected during sleep [27].
Since groups were similar in several child or family factors,
including ADHD score and AHI in children, and the prevalence of
a positive family history of RLS, differences between groups do
not appear to be inﬂuenced by these potential confounding vari-
ables. Also, given that only three subjects were included in this
study and in the infancy one [21], it is difﬁcult to have a hypothesis
regarding the fact that there were no differences in leg activity
between groups at 1–1.5 years of age and the difference in PLMS
index several years later. Further, the methodology used for leg
movement detection in infancy (actigraphy) and childhood
(polysomnography, tibialis anterior EMG) studies might help in
1010 P. Peirano et al. / Sleep Medicine 13 (2012) 1006–1012understanding the absence in infancy and the presence of leg activ-
ity differences in childhood.
Considering that the diagnosis of deﬁnite RLS in children and
adolescents could be preceded by many years of persistent sleep
disturbances, periodic limb movement disorder (PLMD), or possi-
ble/probable RLS [33], a developmental approach deserves special
attention. In this context, children with PLMD have been character-
ized as having important clinical and polysomnographic correlates,
including sleep onset and maintenance problems, leg pain/discom-
fort at night, parasomnias, getting out of bed at night, and family
history of RLS [34]. On PSG recordings they present more awaken-
ings, stage 1 sleep, stage shifts, and spontaneous arousals. In our
study, compared to controls, former IDA children show similar cri-
teria prevalence for RLS [35], but have longer sleep latency in PSG
recordings that could relate to sleep onset problems seen in PLMD
children. However, they also have other characteristics that differ
from the PLMD patterns. For instance, based on parental report,
former IDA children were less frequently identiﬁed as restless
sleepers (data not shown) and presented less awakenings and
stage shifts throughout nighttime PSG recordings relative to
controls.
In order to understand how transient infantile IDA might inﬂu-
ence PLMS approximately 10 years later, it is important to consider
the neurophysiology of PLMS. The link could be via dopamine;
dopamine D3 subtype receptors are probably directly involved in
the pathogenesis of PLMS and RLS symptoms [36–38]. These recep-
tors appear to be concentrated in the limbic system and in the
superﬁcial layers of the dorsal horns of the cervical and lumbar re-
gions and intermedio-lateralis gray matter of the spinal cord [39–
42]. Spinal D3 subtype receptors receive dopaminergic projections
from the A11 nuclei, located within the lateral hypothalamus,
which are suspected to play a role in the pathogenesis of RLS and
PLM and are closely related to the central circadian pacemaker of
the suprachiasmatic nuclei [43]. In the spinal cord, dopaminergic
actions from the A11 exert direct inhibitory actions on dorsal neu-
rons and on the sympathetic preganglionic neurons in the interme-
diolateral nucleus. It is thought that A11 similarly limits activity in
the raphe-spinal projections and that a compromise in A11 inhib-
itory function might be able to shift the balance of descending con-
trol of the sympathetic preganglionics neurons toward excitation
[44]. This view is supported by the well-known and marked reduc-
tion of PLMS induced by dopamine-agonist therapy [45,46] (the
ﬁrst-choice treatment for RLS [47–49]), which selectively reduces
a sub-population of the whole LM activity during sleep, with inter-
movement interval of 6–46 s and ranging 2–4 s in duration [50].
This category of LM is especially sensitive to dopaminergic sub-
stances targeting the D3 receptor subtype [51].
Even though it is not clearly established whether dopamine-
antagonists induce PLMS, centrally active dopaminergic antago-
nists exacerbate existing PLMS and clinically worsen RLS, but this
was not the case for a peripherally active dopamine-antagonist
[52]. These ﬁndings emphasize the involvement of central nervous
system dopaminergic function (presumably at the subcortical lev-
els of the brain) in the pathophysiology of PLMS.
Neurotransmitter systems are maturing during key periods of
high risk for ID, and iron is essential for a number of enzymes in-
volved in neurotransmitter synthesis, including tryptophan
hydroxylase (serotonin) and tyrosine hydroxylase (norepinephrine
and dopamine) [53]. Relevant to the issue of long-lasting effects
are ﬁndings in rodent studies showing that only some of the alter-
ations in dopamine, serotonin, and noradrenergic transporters and
receptors were reversible by iron supplementation at weaning
[12,54,55]. Therefore, reduced iron in the brain might cause re-
duced dopaminergic function by decreasing the activity of tyrosine
hydroxylase or the expression of transporters or receptors for
dopamine [56]. The ID hypothesis for RLS is based on autopsyand MRI studies reporting lower iron levels in the substantia nigra
of RLS patients [57,58], on the lower cerebral spinal ﬂuid ferritin
and iron concentrations found in RLS patients with normal serum
iron stores [59,60], and on the impaired capacity to store iron in
the brain of patients with early onset RLS compared to patients
with late-onset RLS [59]. Finally, iron therapy has been demon-
strated to be effective on RLS as well as on PLMS in adult patients
[23,61] and to be associated with clinical improvement in children
with PLMS [62,63].
Our ﬁndings show that transient IDA in infancy is associated
with a neurophysiological ‘‘scar,’’ as shown by our detailed analysis
of PLMS. The changes may be connected to a subtle but polysom-
nographically detectable dopaminergic dysfunction, even at
10 years of age. This is a period of life when clinically relevant
RLS is uncommon [64] and PLMS are not usually observed in nor-
mal conditions [65]. PLMS do not seem to show particular period-
icity, even in children of this age with clinical conditions
characterized by increased leg motor activity during sleep
[66,67]. The statistically signiﬁcant difference observed in this
study for PLMS index and periodicity index cannot be translated
into a clinical signiﬁcance at this stage and only the long-term fol-
low-up of these children will be able to provide information on its
eventual predictive value of an eventual clinical consequence.
There are no population-based or longitudinal data that assess
what proportion of individuals with PLMS eventually exhibit some
or all of the diagnostic criteria for RLS. However, it is now accepted
that PLMS are an endophenotype of RLS [68]. Asymptomatic PLMS
are often a precursor to RLS [33,69], and they are more common in
relatives of RLS patients [70,71] and more prevalent and abundant
in ethnic groups that have the highest frequencies of RLS/PLMS risk
alleles [72]. The possibility that a history of a transient ID might in-
duce a late-onset RLS, even after the re-establishment of normal
values of ferritin, recalls to some extent the symptomatic RLS form
associated with pregnancy. Pregnancy is a strong risk factor for
both ID and a transient form of RLS, which usually disappears after
delivery; however, women who experience RLS symptoms during
pregnancy are more likely to develop a chronic form of RLS later
in their life compared to women who do not [73,74]. Moreover,
there is a positive correlation between the number of pregnancies
and the risk to be affected by RLS [75].
It is not possible to know, at this stage, if IDA in infancy is a risk
factor for the development of RLS later in life. However, our ﬁndings
warrant continued follow-up. If this sleep motor phenomenon is
further enhancedwith advancing age, transient infantile IDA, a com-
mon nutritional problem among human infants [1–5], may turn out
to be important for understanding the mechanisms of PLMS and,
maybe, of RLS, a common sleep disturbance of adulthood [64,76].Conﬂict of Interest
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